Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in tumor-associated immune cells
Kaipeng Jin, Chao Qian, Jinti Lin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Antioxidant Metabolism Pathways in Vitamins, Polyphenols, and Selenium: Parallels and Divergences
Celia María Curieses Andrés, José Manuel Pérez de la Lastra, Celia Andrés, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2600-2600
Open Access | Times Cited: 38
COX 2-inhibitors; a thorough and updated survey into combinational therapies in cancers
Paul Rodrigues, Harun Bangali, Ahmad Hammoud, et al.
Medical Oncology (2024) Vol. 41, Iss. 1
Closed Access | Times Cited: 16
Prostaglandin E2 in the Tumor Microenvironment, a Convoluted Affair Mediated by EP Receptors 2 and 4
Ana Santiso, Ákos Heinemann, Julia Kargl
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 388-413
Open Access | Times Cited: 16
Plant Foods and Their Bioactives as Dietary Enhancers for Colon Cancer Treatment with 5-Fluorouracil
Zhongming Yang, Carlos L. Céspedes, Zhongguo Yang, et al.
Food Reviews International (2025), pp. 1-50
Closed Access | Times Cited: 6
Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
Kun Huang, Ying Han, Yihong Chen, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Exploration of anti-inflammatory activity of pyrazolo[3,4-d]pyrimidine/1,2,4-oxadiazole hybrids as COX-2, 5-LOX and NO release inhibitors: Design, synthesis, in silico and in vivo studies
M. Abdel Aziz, Ibrahim M. Salem, Mohammed A. AlAwadh, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108181-108181
Closed Access | Times Cited: 2
The Role of Prostaglandin Pathway and EP Receptors in Skin Cancer Development
Anna St. Denis, Rebecca A. Simonette, Peter L. Rady, et al.
International Journal of Dermatology (2025)
Closed Access | Times Cited: 2
MDSC checkpoint blockade therapy: a new breakthrough point overcoming immunosuppression in cancer immunotherapy
Abdulrahman Ibrahim, Nada Mohamady Farouk Abdalsalam, Zihao Liang, et al.
Cancer Gene Therapy (2025)
Open Access | Times Cited: 2
Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization
Sumei Chen, Haitao Zhu, Youssef Jounaïdi
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy
Xiao Dong, Xia Shu, Shubo Du, et al.
ACS Central Science (2023) Vol. 9, Iss. 10, pp. 1864-1893
Open Access | Times Cited: 21
Targeting anticancer immunity in oral cancer: Drugs, products, and nanoparticles
Liling Qin, Jianan Wu
Environmental Research (2023) Vol. 239, pp. 116751-116751
Closed Access | Times Cited: 20
Mesenchymal stromal cell derived extracellular vesicles as a therapeutic tool: immune regulation, MSC priming, and applications to SLE
Christophe Wong, Ivana Stoilova, Florence Gazeau, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Epigenetic modulation of cytokine expression in gastric cancer: influence on angiogenesis, metastasis and chemoresistance
María Elena Reyes, Victoria Pulgar, Carolina Vivallo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
High hypoxia status in pancreatic cancer is associated with multiple hallmarks of an immunosuppressive tumor microenvironment
Hassan Sadozai, Animesh Acharjee, Hateem Zafar Kayani, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Targeting cyclooxygenase-2 for chemoprevention of inflammation-associated intestinal carcinogenesis: An update
Kyung‐Soo Chun, Eun‐Hee Kim, Do‐Hee Kim, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116259-116259
Closed Access | Times Cited: 7
Zhilining Formula alleviates DSS-induced colitis through suppressing inflammation and gut barrier dysfunction via the AHR/NF-κBp65 axis
Rui Zhou, Kaiwen Huang, Simin Chen, et al.
Phytomedicine (2024) Vol. 129, pp. 155571-155571
Closed Access | Times Cited: 5
GC-MS and HPTLC bioautography-based phytochemical profiling and evaluation of biological activity Neptunia prostrata Linn whole plant and leaves
Honey Jajo, Tania Baishya, Priya Das, et al.
Pharmacological Research - Natural Products (2024) Vol. 2, pp. 100013-100013
Closed Access | Times Cited: 4
Involvement of Cyclooxygenase-2 in Establishing an Immunosuppressive Microenvironment in Tumorspheres Derived from TMZ-Resistant Glioblastoma Cell Lines and Primary Cultures
Francesca Lombardi, Francesca Rosaria Augello, Serena Artone, et al.
Cells (2024) Vol. 13, Iss. 3, pp. 258-258
Open Access | Times Cited: 4
Hydrolyzed oyster extracts suppress lipopolysaccharide-mediated inflammation and oxidative stress in RAW264.7 murine macrophages
Seon Yeong Ji, EunJin Bang, Hyun Hwangbo, et al.
Biotechnology and Bioprocess Engineering (2024) Vol. 29, Iss. 3, pp. 494-504
Closed Access | Times Cited: 4
Ferroptosis in glioma therapy: advancements in sensitizing strategies and the complex tumor-promoting roles
Soo Yeon Kim, Miaolu Tang, Tong Lu, et al.
Brain Research (2024) Vol. 1840, pp. 149045-149045
Closed Access | Times Cited: 4
Emerging COX-2 inhibitors-based nanotherapeutics for cancer diagnosis and treatment
Ruiping Huang, Yu Jiang, Baoyue Zhang, et al.
Biomaterials (2024) Vol. 315, pp. 122954-122954
Closed Access | Times Cited: 4
Inflamação Crônica e Tumorigênese: mecanismos biológicos e progressão tumoral
Marcela Álvares Maciel, Ana Maria Aguiar Nascimento, Théo Vitor Magalhães de Queiroz, et al.
Journal of Medical and Biosciences Research. (2025) Vol. 2, Iss. 1, pp. 41-51
Closed Access
Extra Virgin Olive Oil Polyphenol-Enriched Extracts Exert Antioxidant and Anti-Inflammatory Effects on Peripheral Blood Mononuclear Cells from Rheumatoid Arthritis Patients
Bartolo Tamburini, Diana Di Liberto, Giovanni Pratelli, et al.
Antioxidants (2025) Vol. 14, Iss. 2, pp. 171-171
Open Access
The Potential Role of PD-1/PD-L1 Small Molecule Inhibitors in Colorectal Cancer with Different Mechanisms of Action
Suhaibee Kuno, Nattaporn Pakpian, Chatchai Muanprasat
European Journal of Pharmacology (2025), pp. 177351-177351
Closed Access
A phase I dose-escalation and expansion study of RMX1002, a selective E-type prostanoid receptor 4 antagonist, as monotherapy and in combination with anti-PD-1 antibody in advanced solid tumors
Dan Liu, Jifang Gong, Jian Zhang, et al.
Investigational New Drugs (2025)
Open Access
Page 1 - Next Page

Scroll to top